Table 2.
Study (first author) | Coil type | Company | Magnetic (T) | Methods | b value | ADC value (mm^2/s) | |
---|---|---|---|---|---|---|---|
| |||||||
Patients | Control | ||||||
Hosonuma | body and spine matrix coil | SIEMENS AG | 1.50 | HSI; ADC | 50; 800 | 1.19 | 1.37 |
Soyer | anterior torso phased-array coil | Siemens Healthcare | 1.50 | HSI; ADC | 0; 500; 100 | 1.04 | 1.39 |
Ichikawa | Phased-array body coil | GE Healthcare | 1.50 | HSI | 0; 1000 | - | - |
Rao | Phased-array body coil | Siemens AG | 1.50 | HSI | 0; 1000 | - | - |
Colosio | abdominal phased-array coil | Siemens Healthcare | 1.50 | HSI | 0; 500; 1000 | - | - |
Lambregts | Phased-array body coil | Philips Medical | 1.50 | HSI | 0; 500; 1000 | - | - |
Kilickesmez | Phased-array body coil | Siemens Healthcare | 1.50 | ADC | 0; 500; 1000 | 0.97 | 1.37 |
Nural | Phased-array body coil | Siemens Magnetom | 1.50 | HSI | 0; 800 | 1.07 | 1.91 |
Solak | Phased-array body coil | Siemens-Espree | 1.50 | HSI; ADC | 0; 800 | 1.19 | 2.69 |
Avcu | Phased-array body coil | Siemens Magnetom | 1.50 | ADC | 0; 800 | 1.02 | 1.53 |
HSI: Lesions were identified as malignant with the appearance of focal areas of high signal intensity. ADC: Lesions were identified as malignant with significant lower ADC value.